Removal of pharmaceuticals in biological wastewater treatment plants

Fate of Pharmaceuticals in the Environment and in Water Treatment Systems

Volumn , Issue , 2007, Pages 349-362

  Kim, Sungpyo ^a   Weber, A Scott ^b   Batt, Angela ^c   Aga, Diana S ^d  

^a Department of Earth and Environmental Sciences   (United States)

^b State University of New York   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012017577     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420052336     Document Type: Chapter

References (53)

1. Saeijs, H.L. and Van Berkel, M.J., Global water crisis: the major issue of the 21st century, a growing and explosive problem, Eur. Water Poll.Cont., 5, 26, 1995.
2. Papaiacovou, I., Case study—Wastewater reuse in limassol as an alternative water source, Desalination, 138, 55, 2001.
3. Sedlak, D.L., Gray, J.L., and Pinkston, K.E., Understanding microcontaminants in recycled water, Environ. Sci. Technol., 34, 509A, 2000.
4. Glassmeyer, S.T. et al., Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination, Environ. Sci. Technol., 39, 5157, 2005.
5. Kolpin, D.W. et al., Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance, Environ. Sci. Technol., 36, 1202, 2002.
6. de Mes, T., Zeeman, G., and Lettinga, G., Occurrence and fate of estrone, 17-estradiol and 17-ethynylestradiol in STPs for domestic wastewater, Rev. Environ. Sci. Biotechnol., 4, 275, 2005.
7. Sumpter, J.P. and Johnson, A.C., Response to comment on “lessons from endocrine disruption and their application to other issues concerning trace organics in the aquatic environment,” Environ. Sci. Technol., 40, 1086, 2006.
8. Walter, M.V. and Vennes, J.W., Occurrence of multiple-antibiotic enteric bacteria in domestic sewage and oxidation lagoons, Applied Environ. Micro., 930, 1985.
9. Guardabassi, L. et al. Antibiotic resistance in Acinetobacter spp. isolated from sewers receiving waste effluent from a hospital and a pharmaceutical plant, Applied Environ. Micro., 3499, 1998.
10. Kim, S. et al., Tetracycline as a selector for resistant bacteria in activated sludge, Chemosphere, 66, 1643, 2007.
11. Hirsch, R. et al., Occurrence of antibiotics in the aquatic environment, Sci. Total Environ., 225, 109, 1999.
12. Carballa, M. et al., Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Res., 38, 2918, 2004.
13. Halling-Sørensen, B. et al., Occurrence, fate and effects of pharmaceutical substances in the environment—A review, Chemosphere, 36, 357, 1998.
14. Grady, C.P.L., Daigger, G.T., and Lim, H.C., Biological Wastewater Treatment, 2nd ed., Marcel Dekker, New York, 1999.
15. Daughton, C.G. and Ternes, T.A., Pharmaceuticals and personal care products in the environment: agents of subtle change?, Environ. Health Perspec. Suppl., 107, 907, 1999.
16. Stumpf, M. et al., Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil, Sci. Total Environ., 225, 135, 1999.
17. Jorgensen, S.E. and Halling-Sorensen, B., Drugs in the environment, Chemosphere, 40, 691, 2000.
18. Jones, O.A.H., Voulvoulis, N., and Lester, J.N., Human pharmaceuticals in the aquatic environment—A review, Environ. Technol., 22, 1383, 2001.
19. Kümmerer, K., Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources—A review, Chemosphere, 45, 957, 2001.
20. Giger, W. et al., Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters, Chimia Int. J. Chem., 57, 485, 2003.
21. Gobel, A. et al., Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment, Environ. Sci. Technol., 39, 3981, 2005.
22. Lindberg, R.H. et al., Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden, Environ. Sci. Technol., 39, 3421, 2005.
23. Ternes, T.A., Joss, A., and Siegrist, H., Scrutinizing pharmaceuticals and personal care products in wastewater treatment, Environ. Sci. Technol., 38, 392A, 2004.
24. Jones, O.A.H., Lester, J.N., and Voulvoulis, N., Pharmaceuticals: a threat to drinking water? Trends Biotech., 23, 163, 2005.
25. Thomas, P.M. and Foster, G.D., Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process, Environ. Toxic. Chem., 24, 25, 2005.
26. Batt, A.L., Bruce, I.B., and Aga, D.S., Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges, Environ. Poll., 142, 295, 2006.
27. Golet, E.M., Alder, A.C., and Giger, W., Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley watershed, Switzerland. Environ. Sci. Technol., 36, 3645, 2002.
28. Metcalfe, C.D. et al., Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower great lakes, Canada, Environ. Toxic. Chem., 22, 2881, 2003.
29. Petrovic, M., Gonzalez, S., and Barcelo, D., Analysis and removal of emerging contaminants in wastewater and drinking water. TrAC, Trends Anal. Chem., 22, 685, 2003.
30. Ashton, D., Hilton, M., and Thomas, K.V., Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom, Sci. Total Environ., 333, 167, 2004.
31. Ingerslev, F. and Halling-Sorensen, B., Biodegradability properties of sulfonamides in activated sludge, Environ. Toxic. Chem., 19, 2467, 2000.
32. Ternes, T.A. et al. Removal of pharmaceuticals during drinking water treatment, Environ. Sci. Technol., 36, 3855, 2002.
33. Perez, S., Eichhorn, P., and Aga, D.S, Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment, Environ. Toxic. Chem., 24, 1361, 2005.
34. Joss, A. et al., Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme, Water Res., 40, 1686, 2006.
35. Ternes, T.A. et al., Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse, Report EU-POSEIDON project, EVK1-CT-2000-00047, Germany, 2004.
36. Kümmerer, K., Significance of antibiotics in the environment, J. Antimicrob. Chemo., 52, 5, 2003.
37. Eichhorn, P. et al., Application of ion trap-ms with h/d exchange and qqtof-ms in the identification of microbial degradates of trimethoprim in nitrifying activated sludge, Anal. Chem., 77, 4176, 2005.
38. Golet, E.M. et al., Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil, Environ. Sci. Technol., 37, 3243, 2003.
39. Kim, S. et al., Removal of antibiotics in wastewater: effect of hydraulic and solids retention times on the fate of tetracycline in the activated sludge process, Environ. Sci. Technol., 39, 5816, 2005.
40. Stuer-Lauridsen, F. et al., Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use, Chemosphere, 40, 783, 2000.
41. Joss, A. et al., Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res., 39, 3139, 2005.
42. Drewes, J.E., Heberer, T., and Reddersen, K., Fate of pharmaceuticals during indirect potable reuse, Water Sci. Technol., 46, 73, 2002.
43. ES&T, http://pubs.acs.org/subscribe/journals/esthag-w/2006/dec/science/kc_remove_ppcp.html?sa_campaign=rss/cen_mag/estnews/2006-12-27/kc_remove_ppcp (accessed August 8, 2007).
44. Liao, B.Q. et al., Surface properties of sludge and their role in bioflocculation and settleability, Water Res., 35, 339, 2001.
45. Lee, W.T., Kang, S., and Shin, H., Sludge characteristics and their contribution to microfiltration in submerged membrane bioreactors, J. Memb. Sci., 216, 217, 2003.
46. Harper, Jr. W.F. and Yi, T., Sorption of ethinyl estradiol in activated sludge processes, Proceedings of the 25th Annual Alabama Water Environ. Assoc. Con., 2004.
47. Sithole, B.B. and Guy, R.D., Models for tetracycline in aquatic environments: i. interaction with bentonite clay systems, Water Air Soil Poll., 32, 303, 1987.
48. Batt, A.L., Kim, S., and Aga, D.S., Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere, 68, 428, 2007.
49. Rasche, M.E., Hyman, M.R., and Arp, D.J., Factors limiting aliphatic chlorocarbon degradation by Nitrosomonas europaea: cometabolic inactivation of ammonia monooxygenase and substrate specificity, Applied Environ. Micro., 57, 2986, 1991.
50. Keener, W.K. and Arp, D.J., Transformations of aromatic compounds by Nitrosomonas europaea, Applied Environ. Micro., 60, 1914, 1994.
51. Batt, A.L., Kim, S. and Aga, D. S., Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge, Environ. Sci. Technol., 40, 7367, 2006.
52. Köhler, A. et al., Organic pollutant removal versus toxicity reduction in industrial wastewater treatment: the example of wastewater from fluorescent whitening agent production, Environ. Sci. Technol., 40, 3395, 2006.
53. Isidori, M. et al., A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: furosemide and its photoproduct, Chemosphere, 63, 785, 2006.